About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Annals of Oncology
›
Top Articles
Annals of Oncology
Hematology
,
Oncology
10.3
(top 8%)
Impact Factor
11.2
(top 8%)
extended IF
255
(top 1%)
H-Index
7.3K
authors
15.9K
papers
626.4K
citations
9.3K
citing journals
161.6K
citing authors
Most Cited Articles of Annals of Oncology
Title
Year
Citations
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
2013
2K
Estimates of the cancer incidence and mortality in Europe in 2006
2007
1.8K
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
2016
1.7K
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
2015
1.4K
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
2007
1.2K
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
2004
1.1K
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
2015
1.1K
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017
1.1K
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009
2009
1K
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making
2012
984
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015
962
Cancer incidence and mortality in Europe, 2004
2005
909
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018
897
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
2020
838
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
2015
828
Heating the patient: a promising approach?
2002
816
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016
796
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2019
784
Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005
2005
783
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
2014
780
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
2008
771
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
2004
754
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017
751
Worldwide burden of cervical cancer in 2008
2011
722
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014
702
previous
2007
2008
2009
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.